MX5996E - Procedimiento para la elaboracion de preparaciones solidas de alta estabilidad que contienen gefarnate - Google Patents

Procedimiento para la elaboracion de preparaciones solidas de alta estabilidad que contienen gefarnate

Info

Publication number
MX5996E
MX5996E MX797810U MX781079U MX5996E MX 5996 E MX5996 E MX 5996E MX 797810 U MX797810 U MX 797810U MX 781079 U MX781079 U MX 781079U MX 5996 E MX5996 E MX 5996E
Authority
MX
Mexico
Prior art keywords
procedure
preparation
high stability
preparations containing
solid high
Prior art date
Application number
MX797810U
Other languages
English (en)
Spanish (es)
Inventor
Muneo Hara
Terutsugu Tsuji
Keiichi Matsuda
Tadashi Umezu
Munetoshi Adachi
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of MX5996E publication Critical patent/MX5996E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX797810U 1978-03-14 1979-03-13 Procedimiento para la elaboracion de preparaciones solidas de alta estabilidad que contienen gefarnate MX5996E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53029746A JPS6026093B2 (ja) 1978-03-14 1978-03-14 ゲフアルナート含有固型製剤の製造方法

Publications (1)

Publication Number Publication Date
MX5996E true MX5996E (es) 1984-09-18

Family

ID=12284653

Family Applications (1)

Application Number Title Priority Date Filing Date
MX797810U MX5996E (es) 1978-03-14 1979-03-13 Procedimiento para la elaboracion de preparaciones solidas de alta estabilidad que contienen gefarnate

Country Status (17)

Country Link
JP (1) JPS6026093B2 (cs)
AR (1) AR218711A1 (cs)
BE (1) BE874795A (cs)
CH (1) CH637827A5 (cs)
CS (1) CS207784B2 (cs)
ES (1) ES478539A0 (cs)
FR (1) FR2419729B1 (cs)
GB (1) GB2016271B (cs)
HK (1) HK49283A (cs)
IE (1) IE48269B1 (cs)
IT (1) IT1162282B (cs)
MT (1) MTP843B (cs)
MX (1) MX5996E (cs)
NL (1) NL7901917A (cs)
PH (1) PH16903A (cs)
PT (1) PT69341A (cs)
ZA (1) ZA791103B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
EP0391851B1 (de) * 1989-04-07 1994-06-22 Ciba-Geigy Ag Pestizide Wirkstoffkonzentrate und ihre Herstellung
TW202539626A (zh) * 2023-12-01 2025-10-16 日商Ea製藥股份有限公司 醫藥組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
JPS5635169B2 (cs) * 1974-02-14 1981-08-15
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate

Also Published As

Publication number Publication date
HK49283A (en) 1983-11-11
IE790725L (en) 1979-09-14
FR2419729A1 (fr) 1979-10-12
ES8200632A1 (es) 1981-11-01
CS207784B2 (en) 1981-08-31
AR218711A1 (es) 1980-06-30
BE874795A (fr) 1979-07-02
GB2016271B (en) 1982-09-02
JPS6026093B2 (ja) 1985-06-21
IT7948332A0 (it) 1979-03-13
NL7901917A (nl) 1979-09-18
FR2419729B1 (fr) 1988-07-08
PH16903A (en) 1984-04-10
CH637827A5 (fr) 1983-08-31
MTP843B (en) 1980-02-11
ES478539A0 (es) 1981-11-01
GB2016271A (en) 1979-09-26
ZA791103B (en) 1980-03-26
IE48269B1 (en) 1984-11-28
PT69341A (fr) 1979-04-01
JPS54122718A (en) 1979-09-22
IT1162282B (it) 1987-03-25

Similar Documents

Publication Publication Date Title
ES481909A0 (es) Procedimiento para la preparacion de nuevas aril-3 eter-5 o-xazolidinonas-2
MX5631E (es) Procedimiento para la preparacion de acil-anilinas
MX5793E (es) Procedimiento para la preparacion de 4-amino-5-alquilsulfonil-orto-anisamidas
ES494634A0 (es) Procedimiento para la preparacion de compuestos de cefem y cefam
ES482499A0 (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
AR230827A1 (es) Procedimiento para la preparacion de isobuteno
AR223833A1 (es) Procedimiento para la preparacion de nuevos derivados antigenos
MX7633E (es) Procedimiento para la preparacion de compuestos de difenileter
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
MX5509E (es) Procedimiento para la preparacion de n-halogenoacetil-fenilaminocarboniloximas
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
MX5898E (es) Procedimiento para la preparacion de 2-amino-4-pirimidonas
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
ES485567A0 (es) Procedimiento para la preparacion de azolilcetales
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
MX149694A (es) Procedimiento para la preparacion de trialcoxisilanos de fenoxialquilo
ES484342A0 (es) Procedimiento para la preparacion de propenilensulfona
MX5955E (es) Procedimiento para la preparacion de derivados de piridoxina
MX152117A (es) Procedimiento para la preparacion de pigmentos de bis-n-dialquilcarbanoil-quinacridona
AR218711A1 (es) Procedimiento para producir preparaciones farmaceuticas solidas que contienen gefarnate
MX5593E (es) Procedimiento mejorado para la preparacion de derivados de ester de n-trifluoroacetil-n-fosfonometilglicina
MX6158E (es) Procedimiento para la preparacion de derivados piperazinilbenzoheterociclicos
MX5445E (es) Procedimiento para la preparacion de derivados de isotiocianobenzotiazol
MX5674E (es) Procedimiento para la preparacion de derivados de la butenofenona
MX151977A (es) Procedimiento para la preparacion de furopiridinonas y furopirazinonas